Get Caitlin Sakdalan's tips and tricks to prepare the perfect egg, bacon, cheese and avocado breakfast sandwich on this episode of In The Know: Cooking Class.
Get Caitlin Sakdalan's tips and tricks to prepare the perfect egg, bacon, cheese and avocado breakfast sandwich on this episode of In The Know: Cooking Class.
The "Global Bioprocessing Equipment Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering.
Sokoman Minerals Corp. (TSXV: SIC) (OTCQB: SICNF) (the "Company" or "Sokoman") is pleased to announce that ongoing Phase 6 drilling at the 100%-owned Moosehead Property has intersected additional near-surface, high-grade gold mineralization at the Footwall Splay/Eastern Trend. Initial results from South Pond confirm two discreet zones with a higher-grade shoot, and an additional zone of mineralization has been intersected in MH-20-115, drilled in the Eastern Trend Main Zone.
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Online Accommodation Booking Market 2021" report has been added to ResearchAndMarkets.com's offering. "Global Online Accommodation Booking Market 2021" provides insights into the current state and trends of the online travel accommodation market worldwide. Among other findings, the publication reveals that for some of the major market players, the disruptions happened in 2020 resulted in substantial loss of market shares, while some were able to keep their positions. Recent developments in the global online accommodation booking market The global online accommodation market on par with the total travel industry underwent substantial disturbances with the onset of the COVID-19. Before the pandemic, the use of mobile devices to book travel accommodation was trending upward, and the share of hotel mobile app usage was the second highest among all applications used for travel purposes. Since the beginning of the health crisis, however, the share dropped by 12 percentage points, according to the publisher's research findings. This follows the general trend of fall in travel sales and travel application usage due to the pandemic; however, future app usage is expected to exceed the pre-pandemic levels. The year 2020 made it clear that technology-driven solutions in the travel and travel accommodation industry will be essential in the future. Specifically, 8 of 10 survey responds from select Asian countries stated that accommodation providers would need to use the latest technologies to make them feel safe. Furthermore, travelers across the globe claimed when it comes to choosing a hotel, they would pay closer attention to health and safety standards in future travel. COVID-19 brought some changes in the travel accommodation market players distribution Globally, when taken on average, Booking.com was the leading website in the category "accommodation and hotels", as of April 2021, despite having seen significant lower revenue in 2020, as revealed in the new publication. Furthermore, some sources also show Airbnb, Agoda, Traveloka, and Go MMT following Booking in the rankings in specific countries, while legacy global online booking company Expedia underwent a substantial loss in market share in many countries of the world in 2020. Report Coverage This report covers the global online travel market for accommodation booking. It takes into account a wide definition of accommodation, including hotel rooms, hostels, apartments, private rooms and others. While the focus is on leisure and unmanaged travel, some sources cited in this report might also include business travel.Besides sales figures, penetration and rankings, this report also reveals important market trends and forecasts.The following global regions are covered in this report: Asia-Pacific, Europe, Latin America, the Middle East and North America, while data availability varied by country. Report Structure The global chapter opens the report, including an overview of global market developments, trends, regional and country comparisons.The rest of the report is divided by regions. The regions are presented in the order of descending total online travel sales.Within each region, regional information is included first, where available, and the countries are also presented in the order of descending online travel sales. Where no comparable sales figures were available, other related criteria such as total E-Commerce sales, online shopper and Internet penetration were applied.In the country sections, the following information is covered, where available: online accommodation booking sales, channels used for booking accommodation, devices used to book accommodation online, share of consumers booking travel accommodation online and the rank of this category among other categories purchased online, and top websites used to book accommodation. Not all types of information mentioned are provided for each country due to varying data availability.For the global and regional sections, also information about overall online travel sales was included as a context for the development of the online accommodation booking segment. Global Overview Online Travel Market Overview & Trends, December 2020Online Travel Sales, in USD billion, 2019 & 2020e & 2023fOnline Travel Sales, in USD billion, 2021f & 2023fTop 10 Online Booking Channels through STAAH Channel Manager, by Rank Based on Confirmed Nights Booked, 2019 & 2020Travel Apps Used, incl. Hotel Apps, in % of Travelers, February 2021Top 10 Accommodation Websites, by Web Visits, in millions, Average Visit Duration, in minutes, Bounce Rate, in %, and Top 5 Countries by Share of Visits, in %, February 2021Gross Travel Booking Sales Value of Booking Holdings Inc., in USD billion, Q4 2019 & Q4 2020Share of Adult Travelers Who Claimed that Accommodations Would Need to Use the Latest Technologies to Make Travelers Feel Safe, by Country, in %, July 2020 Companies Mentioned AgodaApple PayAtlantisBooking GroupBooking Holding Inc.CtripDirect Bookings via STAAHExpedia GroupFewo-directGo MMTGoodle PayHilton HotelsHostelworldHotelbedsLufthansaMakeMyTripMarriot HotelsPayPalPegasusTravelokaVenmo For more information about this report visit https://www.researchandmarkets.com/r/nj45s1 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Sri Lanka’s top court has decided that some provisions of legislation to set up a powerful economic commission in a Chinese-built port city violate the constitution and require approval by a public referendum to become law. At the center of the dispute are fears that the $1.4 billion port city, part of China's sweeping Belt and Road infrastructure initiative, could become a virtual Chinese outpost or colony. Parliament Speaker Mahinda Yapa Abeywardena read out the Supreme Court's ruling on the Colombo Port City Economic Commission Bill on Tuesday.
The top two based on market share are North American leader ChargePoint Holdings (NYSE: CHPT) and leading European provider EVBox, which will soon go public through a merger with SPAC TPG Pace Beneficial Finance (NYSE: TPGY). Investors haven't been able to participate in ownership of charging-station network leaders until recently. Before companies in the sector became the targets of mergers with SPACs, one popular name with investors was Blink Charging (NASDAQ: BLNK).
Crystal Palace have announced Roy Hodgson will leave the club at the end of the season and the veteran boss says he will not manage in the top flight again. The current terms of the 73-year-old’s deal will expire in the summer and he will depart Selhurst Park after the final match of the campaign against Liverpool on Sunday.
Trans women will be allowed to play on women’s rugby teams in France starting next season under a newly-adopted policy.
(Bloomberg) -- U.S. futures rose with stocks Tuesday as optimism that economic reopenings will boost growth outweighed concern about a pick-up in virus cases in parts of Asia. The dollar dipped and oil gained.Contracts on all three U.S. equity benchmarks advanced, led by those on the Nasdaq 100 Index after tech shares slid Monday. Retailers Walmart Inc. and Macy’s Inc. climbed in premarket trading after raising their full-year guidance, while Home Depot Inc. gained as its results beat estimates. Commodity and automotive shares boosted the Stoxx Europe 600 Index, while Asian equities also climbed.The dollar fell toward a four-month low, while U.S. 10-year Treasuries were steady as investors awaited key housing data ahead of minutes due Wednesday from the Federal Reserve’s last meeting. Brent crude at one point topped $70 a barrel in London for the first time since March on signs that reopenings are boosting demand.Stocks have been volatile after climbing to a record in early May as investors assessed economic growth prospects against a Covid-19 resurgence in countries including India. Traders will also parse the Fed minutes for policy discussion about inflation and hints of a timeline for reducing stimulus, after Vice Chair Richard Clarida said Monday that the weak U.S. jobs report showed the economy had not yet reached the threshold to warrant scaling back asset purchases.Global investor sentiment is “unambiguously bullish,” Bank of America Corp. strategists led by Michael Hartnett said, citing the firm’s latest fund manager survey. Inflation topped the list of the biggest tail risks, followed by a bond market taper tantrum and asset bubbles, while Covid-19 was only in fourth place.Elsewhere, Bitcoin was steady following volatility spurred by comments from Tesla Inc.’s Elon Musk. Coinbase Global Inc. fell in premarket trading after Monday’s drop below the reference price used in its April direct listing. AMC Entertainment Holdings Inc. advanced 6.9%, extending its longest rally since 2019.Here are some key events this week:The Fed publishes minutes from its April meeting Wednesday, which may provide clues to officials’ views on the recovery and how they define “transitory” when it comes to inflationEIA crude oil inventory report WednesdaySt. Louis Fed President James Bullard and Atlanta Fed President Raphael Bostic to speak at separate events WednesdayIMF Managing Director Kristalina Georgieva and ECB President Christine Lagarde speak at the Vienna Economic Dialogue ThursdayAustralia unemployment rate ThursdayEuro-area finance ministers and central bank chiefs hold an informal meeting. A larger group of EU finance ministers and central bank chiefs will meet May 22These are some of the main moves in markets:StocksFutures on the S&P 500 rose 0.2% as of 7:29 a.m. New York timeFutures on the Nasdaq 100 rose 0.5%Futures on the Dow Jones Industrial Average rose 0.1%The Stoxx Europe 600 rose 0.3%The MSCI World index rose 0.5%CurrenciesThe Bloomberg Dollar Spot Index fell 0.3%The euro rose 0.5% to $1.2209The British pound rose 0.4% to $1.4188The Japanese yen rose 0.2% to 109.02 per dollarBondsThe yield on 10-year Treasuries was little changed at 1.64%Germany’s 10-year yield was little changed at -0.12%Britain’s 10-year yield was little changed at 0.87%CommoditiesWest Texas Intermediate crude rose 0.2% to $66 a barrelGold futures were little changedMore stories like this are available on bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Covid-19 vaccines can reduce symptoms of Long Covid, a new study has found. A team of researchers discovered that mRNA vaccines, such as Pfizer/BioNTech or Moderna, were the most effective in alleviating some symptoms of the condition. Long Covid, or post-Covid-19 syndrome, affects survivors of the virus even if they've only had mild symptoms when infected, and signs of the condition, including fatigue, insomnia, skin rashes, and brain fog, can last for weeks, if not months. The researchers analysed more than 800 people in the study, who all suffered from Long Covid, and participants were asked to wait a week after receiving their first vaccine before recording their responses. Results showed that 56.7 per cent of respondents experienced an overall improvement in symptoms, with 24.6 per cent unchanged and 18.7 per cent reporting an increase in their symptoms. Those who had Pfizer/BioNTech or Moderna vaccines had more improvements in symptoms, with the latter reducing fatigue, brain fog and muscle pain, compared with those who had the Oxford/AstraZeneca jab. Analysis author Ondine Sherwood, from LongCovidSOS, said the data was "very encouraging", but researchers were unaware of how long the effects would last. Dr David Strain, who also served as an analysis author said that while there wasn't one treatment that would fix everyone with Long Covid, the initial results from the study were positive. “There isn’t a blood pressure tablet that fixes everybody... and similarly, there’s not one Long Covid treatment that’s going to fix everyone – but the fact that one treatment does fix something means that there’s bound to be other treatments out there that will fix others," he explained.
Nathalie Emmanuel and Garrett Hedlund have signed up to star in the Dracula-inspired horror-thriller The Bride. The Fast & Furious actress and Tron: Legacy actor will be directed by The Light of the Moon filmmaker Jessica M. Thompson in the project, which is being described as a contemporary horror-thriller inspired by Bram Stoker's Dracula. It tells the story of a young woman who is courted and swept off her feet, only to realise a gothic conspiracy is afoot. According to Deadline, executives at Screen Gems see the film as the start of a potential franchise and studio officials have fast-tracked production, with cameras set to roll at the end of summer. Australian filmmaker Thompson, who was first announced as the director of the project in June last year, shared the Deadline article on Instagram and wrote in the caption, "We’re making a movie! Pretty (bram) stoked about this one #nathalieemmanuel #garretthedlund #womeninfilm #femalefilmmakers #womeninhorror #dracula." She also shared the news on her Instagram Stories and wrote that the team she's assembled for the project is made up of "wildly talented humans" and added GIFs of a film camera, fireworks, and dripping blood. Blair Butler wrote the original script based on her pitch, with Thompson making revisions, and Emile Gladstone will serve as producer. Emmanuel, who is well-known for playing Missandei in Game of Thrones, will next be seen reprising her role as Ramsey, a British computer hacker, in Fast & Furious 9, or F9, when it is released next month after being delayed for a year due to the pandemic. Hedlund was mostly recently seen in The United States vs. Billie Holiday and his upcoming projects include The Ploughman, which is being directed by Ed Harris.
Clearview AI, the leading facial recognition company that provides its services to law enforcement, added 3 top professionals to its leadership team.
Sodium Chloride Market Research Report by Grade (Rock Salt, Solar Salt, and Vacuum Salt), by Application (Chemical Production, Deicing, Feed Additive, Flavoring Agent & Food Preservative, and Pharmaceutical) - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, May 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Sodium Chloride Market Research Report by Grade, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05911561/?utm_source=GNW Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Sodium Chloride Market is expected to grow from USD 19,833.99 Million in 2020 to USD 23,874.31 Million by the end of 2025.2. The Global Sodium Chloride Market is expected to grow from EUR 17,390.82 Million in 2020 to EUR 20,933.45 Million by the end of 2025.3. The Global Sodium Chloride Market is expected to grow from GBP 15,460.47 Million in 2020 to GBP 18,609.88 Million by the end of 2025.4. The Global Sodium Chloride Market is expected to grow from JPY 2,116,789.46 Million in 2020 to JPY 2,547,994.57 Million by the end of 2025.5. The Global Sodium Chloride Market is expected to grow from AUD 28,801.59 Million in 2020 to AUD 34,668.68 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Sodium Chloride to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Grade, the Sodium Chloride Market studied across Rock Salt, Solar Salt, and Vacuum Salt. Based on Application, the Sodium Chloride Market studied across Chemical Production, Deicing, Feed Additive, Flavoring Agent & Food Preservative, Pharmaceutical, and Water Treatment. Based on Geography, the Sodium Chloride Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Sodium Chloride Market including Agrosal GmBH, Akzo Nobel N.V., Cargill Incorporated, Compass Minerals International Inc, Compass Minerals International, Inc., Dominion Salt Ltd, Dow Chemical Company Ltd., Gulkas Pharma Private Limited, Hebei Huachen Pharmaceutical Co., Ltd., HubPak, ICL Fertilizers, INEOS AG, K+S France S.A.S, Merck KGaA, Nouryon Holding B.V., Pon Pure Chemicals Group, SSP Pvt Limited, Swiss Salts Works AG, Südwestdeutsche Salzwerke AG, Tata Chemicals Ltd., and Wacker Chemie AG. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sodium Chloride Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Sodium Chloride Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sodium Chloride Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sodium Chloride Market?4. What is the competitive strategic window for opportunities in the Global Sodium Chloride Market?5. What are the technology trends and regulatory frameworks in the Global Sodium Chloride Market?6. What are the modes and strategic moves considered suitable for entering the Global Sodium Chloride Market?Read the full report: https://www.reportlinker.com/p05911561/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
J.J. Abrams has confirmed he won't direct the upcoming Black Superman movie. Warner Bros. officials announced in February that the Star Wars: The Force Awakens director was producing a Black Superman movie and author and journalist Ta-Nehisi Coates was writing the screenplay, but no details were shared about the director or the lead actor. In an interview with Yahoo! Entertainment, Abrams confirmed that he will not be helming the superhero reboot. "I will not be directing that movie," he stated. "But I will say it's a project that means an enormous amount to us and when the time is right I really can't wait to talk about it, but unfortunately, that time is not now, but I look forward to that happening when it does." His confirmation comes shortly after The Hollywood Reporter published a report suggesting that Abrams is not being considered for the directing job because Warner Bros. and DC Comics officials feel it would be "tone-deaf" to hire him and they are actively seeking a Black filmmaker to take the reins. While no official announcements have been made about who will play Superman, Michael B. Jordan recently declared that he wasn't in the running for the role. In a separate interview with Collider, Abrams shared that he is unlikely to direct any of the DC films his production company Bad Robot has in the pipeline as he is keen to return to original ideas after a long run of directing franchises. "I feel like, as someone who started writing in television and telling original stories on film and in TV, it is something that I really do miss," he shared. "The few things that I'm working on now, as a writer, are original ideas. I just feel, as a director, I really would love to have my next projects be things that didn't pre-exist me necessarily." Abrams, who has directed two Star Wars films, two Star Trek movies, and a Mission: Impossible instalment, last helmed an original film with 2011's Super 8.
Scientists have discovered a link between the presence of specific bacterial genes in the gut and multiple diseases. Researchers from the Harvard Medical School and Joslin Diabetes Center analysed the genetic make-up of bacteria in the human gut and successfully linked groups of bacterial genes, known as "genetic signatures", to the presence of diseases and conditions such as coronary artery disease, cirrhosis of the liver, inflammatory bowel disease, colon cancer, and Type 2 diabetes. The findings showed that coronary artery disease, inflammatory bowel disease, and liver cirrhosis share many of the same bacterial genes, meaning people who have guts harbouring these genes seem more likely to have one or more of these conditions. In contrast, they found Type 2 diabetes has a microbiome signature unlike any other phenotype the team tested. The researchers said their study represents a significant advance in the understanding of the link between microbes in the gut and specific diseases, and could eventually pave the way for scientists to develop tests that could gauge a person's risk of a range of conditions using a stool sample. "This opens a window for the development of tests using cross-disease, gene-based indicators of patient health," said first author Braden Tierney. "We've identified genetic markers that we think could eventually lead to tests, or just one test, to identify associations with a number of medical conditions." The experts, who collected microbiome data from 13 groups of patients resulting in more than 2,500 samples for their study, have warned that their investigations require further research because it currently remains unclear whether these bacterial genes have a role to play in the development of diseases or are simply bystanders. Senior author Chirag Patel also explained their findings showed that it wasn't just the presence of specific bacterial families that indicated risk, but rather the strains and gene signatures of them that are the most important. The findings were published in Nature Communications.
The Covid-19 pandemic has put a spotlight on mental health, and perfectionism is yet another issue causing rising concern among health experts. Perfectionism is often defined as "the need to be or appear to be perfect, or even to believe that it's possible to achieve perfection". While it is usually viewed as a positive characteristic rather than a flaw, there are times when the pressure to avoid making mistakes becomes overwhelming and is detrimental to our health. Perfectionism can stop people from trying new things or completing tasks, especially when it comes to education, work, relationships or our appearance. It may mean we miss out on new opportunities because we are afraid of failing, and our own unrealistic expectations can lead to procrastination and anxiety. Perfectionism often triggers anxiety and leaves you feeling exhausted and unable to make decisions, with physical symptoms including an upset stomach, headaches, racing heart and tension in the neck and temples. Angela Bryant, the founder of independent business review site angelrated.com, has shared some important signs to look out for if you suspect you or someone else may be battling perfectionism: -Being highly critical of your own work and that of others, taking pride in spotting (and correcting!) tiny mistakes and imperfections. -Setting unrealistic standards that you expect others to meet. -Being driven by a fear of failure/of trying to prove that you are perfect. -Beating yourself up at the end of each day if you haven't achieved everything that you wanted to. -Procrastinating because you are so worried about starting and failing. As with many mental health issues, getting to the root of its cause is an important part of developing coping strategies. Angela believes looking back at childhood experiences is a good place to start. It's also helpful to pinpoint triggers to understand what is fuelling your perfectionism - are you afraid to fail at work? Or are you dreading upcoming exams? Have you had a bad relationship in the past? Getting to grips with exactly what is worrying you is crucial. Here are Angela's top tips for dealing with perfectionism: -Recognise what is driving your perfectionism and try to understand where it came from (your childhood, the media, etc). -Keep a list of examples of when you finished something that wasn't 'perfect' and nothing bad happened/it was still a success. -Break goals down into bite-size chunks so you don't fall into the all-or-nothing mindset of either wanting to complete everything or not do it at all. -Keep repeating the mantra progress, not perfection!
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Healthcare/Medical Simulation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Healthcare/Medical Simulation Market to Reach $5.9 Billion by 2027Amid the COVID-19 crisis, the global market for Healthcare/Medical Simulation estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 15.9% over the analysis period 2020-2027. Healthcare Anatomical Models, one of the segments analyzed in the report, is projected to record a 17.2% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Web-based Simulators segment is readjusted to a revised 16.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $619.7 Million, While China is Forecast to Grow at 15.2% CAGRThe Healthcare/Medical Simulation market in the U.S. is estimated at US$619.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 15.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.5% CAGR.Healthcare Simulation Software Segment to Record 15.4% CAGRIn the global Healthcare Simulation Software segment, USA, Canada, Japan, China and Europe will drive the 15.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$286.5 Million in the year 2020 will reach a projected size of US$770.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$701.9 Million by the year 2027.Key Topics Covered: I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS(Total 35 Featured): 3D SystemsCAECardionics, Inc.Gaumard Scientific CompanyKyoto KagakuLaerdal MedicalLimbs & ThingsMedaphorMentice ABOperative Experience, Inc.Simulab CorporationSimulaidsSynBone AGVirtaMed AGVRMagic Holding AG 3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Healthcare/Medical Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Healthcare Anatomical Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Web-based Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Healthcare Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Simulation Training Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Military Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR III. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 35 For more information about this report visit https://www.researchandmarkets.com/r/dl972u CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Former champion Stan Wawrinka has pulled out of the French Open after failing to recover sufficiently from an operation he underwent on his left foot in March, a source told Reuters on Tuesday. The 36-year-old Swiss, who won the claycourt Grand Slam at Roland Garros in 2015, has not played on the Tour since his opening round loss in March. The three-times Grand Slam champion, a former world number three, then underwent a minor procedure on his left foot and at the time said he will be out for a few weeks.
Skit followed announcement that DeGeneres was ending her talk show after 19 years
We've got your back
La corsa della campagna vaccinale a immunizzare il maggior numero di italiani deve fare i conti con uno zoccolo duro di connazionali 'in fuga' dal vaccino. Un gruppo eterogeneo di persone che, per diversi motivi, potrebbe anche non vaccinarsi mai contro il Covid. Una prima fotografia di questo fenomeno è stata fatta dal commissario straordinario all'emergenza, il generale Figliuolo a inizio maggio: "I no-vax nel Nord-Est del Paese sono il 18%, nelle altre Regioni siamo al 10-12%. Il fenomeno - spiegava in una intervista - è statisticamente rilevante se sale sopra il 5%". Gli italiani quindi che molto probabilmente non faranno il vaccino o aspetteranno fino all'ultimo sono circa 5 milioni, calcolando che sono 50 mln gli over 16. Ieri a Roma si è svolta una manifestazione no-vax che ha radunato migliaia di persone, anche medici, contrarie al vaccino Covid. L'ultimo di tanti eventi che ogni settimana si svolgono nelle piazze italiane. Accanto a questo fenomeno ci sono i dati rilevati al 17 maggio dalla Fondazione Gimbe, un indicatore di come questo zoccolo duro sia trasversale. Il report Gimbe che analizza l'andamento delle immunizzazioni ha rilevato che "il 22,6% della popolazione 70-79anni e il 9% degli over 80 non hanno ricevuto neanche una dose". In questa analisi "non sono noti i numeri sulle mancate adesioni e i rifiuti selettivi (ad esempio per AstraZeneca)", sottolinea la Fondazione Gimbe all'Adnkronos Salute. "Considerato che la campagna vaccinale sta entrando in una fase condizionata dall’adesione della popolazione, occorre integrare la prenotazione volontaria con un sistema a chiamata attiva - propone la Fondazione - coinvolgendo in maniera sistematica e capillare i medici di famiglia e mettendo in campo un’adeguata campagna di comunicazione istituzionale e strategie di persuasione individuale". I medici di famiglia si trovano a dover sopperire "ai limiti di una campagna vaccinale pensata per grandi numeri e non per le esigenze del singolo paziente magari anziano, fragile e solo - spiega all'Adnkronos Salute Pierluigi Bartoletti, segretario provinciale della Fimmg Roma, la Federazione dei medici di famiglia - Tra i miei 1.110 assistiti in questi mesi ho avuto a che fare solo con due no-vax. Se c'è una percentuale di persone esitanti o non registrate la colpa è del sistema dei grandi 'hub' molto rigido. Questi cittadini vivono lontano dai grandi centri vaccinali, sono soli e non hanno come spostarsi, spesso sono fragili e ancor più spesso non sono registrati nel sistema. Faccio un esempio, un cardiopatico che non ha la 104, non ha nessuna esenzione ed è quindi invisibile al sistema. Ho avuto tante segnalazioni di questi casi, persone rimaste indietro rispetto alla campagna di vaccinazione". Bartoletti segnala anche un problema che si sta verificando nel Lazio. "Se chiedono a me medico di famiglia di convincere questi pazienti dubbiosi al vaccino, perché li conosco bene e posso essere più convincente, mi devono però anche dare i vaccini - avverte - altrimenti, come accaduto con una anziana proprio ieri, l'ho convinta ma dopo non c'era più il vaccino disponibile e poi scopro che avevano organizzato un Open Day. Ecco questo magari non dovrebbe accadere: se mi vengono promesse 50 dosi, poi non ne posso avere 2". "In conclusione il modello 'hub' paga in termini di numeri ma non di servizio - analizza Bartoletti - Noi siamo in prima linea dall'inizio e possiamo dare un grande contributo anche per arrivare là dove il sistema non riesce, ma dobbiamo essere messi nelle condizioni farlo nel migliore dei modi".